[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350440-105":59,"doc-detail-350440-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","fto-mediated-m6a-demethylation-of-bcl6-promotes-gastric-cancer-progression-by-suppressing-ferroptosis","FTO-mediated m6A demethylation of BCL6 promotes gastric cancer progression by suppressing ferroptosis","","B-cell lymphoma 6 (BCL6) shows unclear roles and regulation in gastric cancer (GC), despite its relevance across tumors. N6-methyladenosine (m6A) modification drives tumorigenesis, and the m6A demethylase FTO, highly expressed in GC, may modulate target stability. This study evaluates FTO control of BCL6 m6A modification and its ferroptosis-linked impact on GC progression using expression assays, cell viability and apoptosis readouts, ferroptosis markers, mRNA interaction and stability analyses, and FTO/BCL6 axis perturbation with YTHDF2 involvement.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/fto-mediated-m6a-demethylation-of-bcl6-promotes-gastric-cancer-progression-by-suppressing-ferroptosis/350440/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/fto-mediated-m6a-demethylation-of-bcl6-promotes-gastric-cancer-progression-by-suppressing-ferroptosis/350440.png","ImageObject",300,407,{"name":92,"@type":93},"Grenda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does FTO influence BCL6 in gastric cancer?","Question",{"text":112,"@type":113},"FTO binds BCL6 mRNA, removes m6A, and reduces BCL6 mRNA stability, leading to BCL6 downregulation in GC cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the effect of BCL6 overexpression on GC cells?",{"text":117,"@type":113},"BCL6 overexpression inhibits cell viability, promotes apoptosis, and induces ferroptosis in GC cell models.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the FTO-BCL6 axis affect ferroptosis and GC progression?",{"text":121,"@type":113},"The FTO/BCL6 axis promotes GC progression by inhibiting ferroptosis, and this functional effect can be partially reversed when BCL6 is silenced alongside FTO disruption.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350440,1790614652,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971474921005,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","RESEARCH ARTICLE     \nFTO-mediated m6A demethylation of BCL6 promotes gastric cancer progression by suppressing ferroptosis  \nYan Wang, Fangfang Fan, Zhongmin Zhan, Chenxu Yu and Shengchi Chen  \nDepartment of Medical Oncology, Nanping First Hospital Affiliated to Fujian Medical University, Nanping, China  \nABSTRACT  \nB-cell lymphoma 6 (BCL6) functions in various cancers, but its role and regulation in gastric cancer (GC) remain unclear. N6-methyladenosine (m6A) modification is critical for tumorigenesis, and the demethylase FTO (highly expressed in GC) may regulate target gene stability via m6A. This study explored FTO’s regulation of BCL6 m6A modification and its impact on GC progression through ferroptosis. qPCR assessed BCL6 expression in GC cells. BCL6 overexpression models were used to evaluate cell viability, apoptosis, and ferroptosis (via ROS, Fe2+, MDA, LDH, and ferroptosis-related proteins) . RIP-PCR, MeRIPqPCR, and mRNA stability assays examined FTO-BCL6 mRNA interaction and m6A effects. YTHDF2 knockdown validated its role, and co-silencing FTO/BCL6 clarified the axis’s function. BCL6 was downregulated in GC cells. Its overexpression inhibited cell viability, promoted apoptosis, and induced ferroptosis. FTO bound BCL6 mRNA, removed m6A, and reduced its stability. YTHDF2 mediated FTO’s negative regulation of BCL6 . FTO knockdown enhanced ferroptosis and impaired GC cell function, partially reversed by BCL6 silencing. FTO suppresses BCL6 via m6A demethylation, inhibiting ferroptosis to promote GC progression. The FTO/BCL6 axis is a potential therapeutic target for GC.  \nHIGHLIGHTS  \n(1) BCL6 exhibits low expression in gastric cancer (GC), and its overexpression suppresses tumour growth by inducing ferroptosis.  \n(2) FTO enhances BCL6 mRNA stability through demethylation, dependent on YTHDF2-mediated recognition of m6A modification.  \n(3) The FTO-BCL6 axis promotes GC progression by inhibiting ferroptosis, providing apotential strategy for targeted intervention.  \nARTICLE HISTORY  \nRevised 10 May 2026 Accepted 1 June 2026  \nKEYWORDS  \nGastric cancer (GC); N6-methyladenosine (m6A) modification; BCL6; FTO; ferroptosis  \n1. Introduction  \nGastric cancer (GC) remains one of the leading causes of cancer incidence and mortality worldwide [ 1] . Despite advances in early screening and multimodal therapeutic strategies that have improved survival rates, patients diagnosed at advanced stages continue to face poor prognosis, frequent recurrence, and therapeutic resistance [2,3] . Thus, elucidating the molecular mechanisms underlying GC progression and identifying novel therapeutic targets are urgent needs. Recent studies have highlighted the critical role of epigenetic modifications in tumour biology, particularly the dynamic and reversible N6-methyladenosine (m6A) RNA methylation, which regulates gene expression, RNA stability, and translation efficiency [4] . Dysregulation of m6A modifications has been implicated in the development and progression of various cancers [5,6]; however, the specific regulatory networks and functional consequences of m6A in GC remain to be fully characterized.  \nB-cell lymphoma 6 (BCL6), a zinc-finger transcriptional repressor initially identified in B-cell lymphomas [7], plays essential roles not only in immune system development and inflammatory regulation [8–10], but also in the pathogenesis of multiple solid tumours [ 11, 12] . For example, BCL6 suppresses tumour progression by regulating proliferation and apoptosis in triple-negative breast cancer [ 13] and pancreatic cancer [ 14] . However, the expression pattern and function of BCL6 in GC remain controversial. Several  \nCONTACT Yan Wang  [m13559856686@163.com](m13559856686@163.com)  Department of Medical Oncology, Nanping First Hospital Affiliated to Fujian Medical University, No. 317, Zhongshan Road, Yanping District, Nanping, Fujian 353000, China.  \n© 2026 The Author(s) . Published by Informa UK Limited, trading as Taylor & Francis Group.  ","cbCaipUwjHYd9DJA","https://ap.wps.com/l/cbCaipUwjHYd9DJA","pdf",4942570,14,"English","# Introduction\n## BCL6 and m6A regulation in gastric cancer\n## Ferroptosis and its relevance to tumor therapy\n## FTO as an m6A demethylase","[{\"question\":\"How does FTO influence BCL6 in gastric cancer?\",\"answer\":\"FTO binds BCL6 mRNA, removes m6A, and reduces BCL6 mRNA stability, leading to BCL6 downregulation in GC cells.\"},{\"question\":\"What is the effect of BCL6 overexpression on GC cells?\",\"answer\":\"BCL6 overexpression inhibits cell viability, promotes apoptosis, and induces ferroptosis in GC cell models.\"},{\"question\":\"How does the FTO-BCL6 axis affect ferroptosis and GC progression?\",\"answer\":\"The FTO/BCL6 axis promotes GC progression by inhibiting ferroptosis, and this functional effect can be partially reversed when BCL6 is silenced alongside FTO disruption.\"}]","FTO-mediated m6A demethylation of BCL6 promotes gastric cancer progression by suppressing ferroptosis | PDF",1790089032,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/48dba12a15247efeccc430d796fccc3f.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8918bbf4839a5afb5632e056c6f6526.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d0542ca93b299278149b39df75d8a35.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d89818ab89d7e16f0d8501a6a18a351b.webp",980,1306]